Literature DB >> 1164058

Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow).

H J Wanebo, J G Fortner, J Woodruff, B MacLean, E Binkowski.   

Abstract

The methods of histologic staging of primary Stage I melanoma and the relation to lymph node metastases and survival after surgery was evaluated in 151 patients with extremity melanoma only. Microstaging by depth of invasion showed a better prognostic correlation than by histologic typing (into superficial spreading, or nodular melanoma). A correlation existed between depth of invasion (Clark's levels) and incidence of nodal metastases at elective node dissection. This incidence was 5% at Level II, 4% at Level III, 25% at Level IV and 75% at Level V. The measured depth of invasion added prognostic insight to each Clark's level; the minimal invasion at which nodal metastases occurred was 0.6 mm for Level II, 0.9 mm for Level III, 1.5 mm for Level IV and over 4 mm for Level V. The 5 year disease-free survival after surgery was 100% for Clark Level II, 88% for Level III, 66% for Level VI and 15% for Level V. There was a direct relation between the measured depth of invasion and survival and mortality from disease at 5 years. Mortality from disease at 5 years could be directly equated with 10 times microinvasion in mm. Microstaging by direct measurement gave a better prognostic correlation than was found using Clark's levels for more deeply invading melanoma. At this time there is suggestive evidence that patients with certain higher risk lesions may do significantly better with wide excision and elective node dissection than with wide excision alone. These high risk lesions include Clark Level III to V, lesions measuring 0.9 mm or greater and all nodular melanomas.

Entities:  

Mesh:

Year:  1975        PMID: 1164058      PMCID: PMC1343944          DOI: 10.1097/00000658-197509000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  REGIONAL LYMPH NODE DISSECTION AND MALIGNANT MELANOMA. EFFECT OF SURVIVAL.

Authors:  W E PRICE; M K DUVAL
Journal:  Arch Surg       Date:  1963-11

2.  RESULTS OF GROIN DISSECTION FOR MALIGNANT MELANOMA IN 220 PATIENTS.

Authors:  J G FORTNER; R J BOOHER; G T PACK
Journal:  Surgery       Date:  1964-04       Impact factor: 3.982

3.  LIFE HISTORY OF MELANOMA.

Authors:  G MCNEER; T DASGUPTA
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1965-03

4.  The role of radical regional lymphadenectomy in treatment of melanoma.

Authors:  L W GUISS; I MACDONALD
Journal:  Am J Surg       Date:  1962-08       Impact factor: 2.565

5.  Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults.

Authors:  N LANE; R LATTES; J MALM
Journal:  Cancer       Date:  1958 Sep-Oct       Impact factor: 6.860

6.  Malignant melanoma; clinical and pathologic analysis of 93 cases. Is prophylactic lymph node dissection indicated?

Authors:  R H LUND; M IHNEN
Journal:  Surgery       Date:  1955-10       Impact factor: 3.982

7.  Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis.

Authors:  A C ALLEN; S SPITZ
Journal:  Cancer       Date:  1953-01       Impact factor: 6.860

8.  Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I.

Authors:  N C PETERSEN; D C BODENHAM; O C LLOYD
Journal:  Br J Plast Surg       Date:  1962-01

9.  Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck.

Authors:  M G Hansen; A B McCarten
Journal:  Am J Surg       Date:  1974-10       Impact factor: 2.565

10.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

Authors:  W H Clark; L From; E A Bernardino; M C Mihm
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701

View more
  16 in total

1.  A rational approach to the surgical management of melanoma.

Authors:  E C Holmes; H S Moseley; D L Morton; W Clark; D Robinson; M M Urist
Journal:  Ann Surg       Date:  1977-10       Impact factor: 12.969

2.  Anorectal melanoma.

Authors:  Amalia Stefanou; Surya P M Nalamati
Journal:  Clin Colon Rectal Surg       Date:  2011-09

3.  Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study.

Authors:  T K Gupta
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

4.  Natural history of cutaneous malignant melanoma.

Authors:  H A Briele; T K Das Gupta
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

5.  Surgical treatment of malignant melanoma of the skin.

Authors:  U Veronesi; N Cascinelli
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

6.  The treatment of state I melanoma of the extremities with regional hyperthermic isolation perfusion.

Authors:  K A Janoff; D Moseson; J Nohlgren; C Davenport; C Richards; W S Fletcher
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

7.  Prognostic value of tumour thickness in cutaneous malignant melanoma.

Authors:  I Jeffrey; P Royston; C Sowter; G Slavin; A Price; A Pomerance; S Goolamali; D Pinto
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

8.  Primary melanoma of skin of the breast region.

Authors:  Y T Lee; F C Sparks; D L Morton
Journal:  Ann Surg       Date:  1977-01       Impact factor: 12.969

9.  Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.

Authors:  D G Coit; A Rogatko; M F Brennan
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

10.  A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.

Authors:  C M Balch; T M Murad; S J Soong; A L Ingalls; N B Halpern; W A Maddox
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.